Rockstroh, Jürgen K <br/><br/>
A randomized, double-blind comparison of coformulated elvitegravir/cobicistat/emtricitabine/tenofovir DF vs ritonavir-boosted atazanavir plus coformulated emtricitabine and tenofovir DF for initial treatment of HIV-1 infection: analysis of week 96 results.  [electronic resource] 

 -  Journal of acquired immune deficiency syndromes (1999)  Apr 2013 
 - 483-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1944-7884 
<br/><br/><label>Standard No.: </label>10.1097/QAI.0b013e318286415c  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine--analogs & derivatives<br/>Adult<br/>Alanine Transaminase--blood<br/>Anti-HIV Agents--therapeutic use<br/>Aspartate Aminotransferases--blood<br/>Atazanavir Sulfate<br/>Bilirubin--blood<br/>Bone Density--drug effects<br/>Carbamates--therapeutic use<br/>Cobicistat<br/>Confidence Intervals<br/>Creatinine--blood<br/>Deoxycytidine--analogs & derivatives<br/>Double-Blind Method<br/>Drug Combinations<br/>Emtricitabine<br/>Female<br/>HIV Infections--blood<br/>HIV-1--genetics<br/>Humans<br/>Male<br/>Oligopeptides--therapeutic use<br/>Organophosphonates--therapeutic use<br/>Pyridines--therapeutic use<br/>Quinolones--therapeutic use<br/>RNA, Viral--blood<br/>Ritonavir--therapeutic use<br/>Tenofovir<br/>Thiazoles--therapeutic use<br/>Triglycerides--blood